Penicillin Prophylaxis in Sickle Cell Disease (PROPS)
Status:
Completed
Trial end date:
1994-10-01
Target enrollment:
Participant gender:
Summary
To determine whether the regular daily administration of oral penicillin would reduce the
incidence of documented infection due to Streptococcus pneumoniae in children with sickle
cell anemia.